• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Azo compounds

Chemical Profile of 2-(E)-2-(1-cyano-1,3-dimethylbutyl)diazen-1-yl-2,4-dimethylpentanenitrile (CAS No. 1547296-70-7)

2-(E)-2-(1-cyano-1,3-dimethylbutyl)diazen-1-yl-2,4-dimethylpentanenitrile, identified by the CAS number 1547296-70-7, is a specialized organic compound that has garnered attention in the field of synthetic chemistry and pharmaceutical research. This compound belongs to the class of diazenes, which are azo compounds featuring a nitrogen-nitrogen single bond. The presence of functional groups such as the cyano group and the dimethylbutyl moiety contributes to its unique chemical properties and reactivity, making it a subject of interest for various applications.

The molecular structure of 2-(E)-2-(1-cyano-1,3-dimethylbutyl)diazen-1-yl-2,4-dimethylpentanenitrile consists of an alkylnitrile backbone with an azene substituent at the 1-position. The (E)-configuration of the double bond introduces geometric specificity, which can influence its interaction with biological targets. This compound's synthesis involves multi-step organic transformations, including condensation reactions and diazotization processes, which highlight its complexity and the precision required in its preparation.

In recent years, there has been a growing interest in azene derivatives due to their potential applications as intermediates in pharmaceutical synthesis. The cyano group in this molecule enhances its reactivity, allowing for further functionalization and modification. This property makes it a valuable building block for the development of more complex molecules with tailored biological activities. Researchers have explored its utility in constructing heterocyclic frameworks, which are prevalent in many bioactive compounds.

One of the most compelling aspects of 2-(E)-2-(1-cyano-1,3-dimethylbutyl)diazen-1-yl-2,4-dimethylpentanenitrile is its potential role in medicinal chemistry. The combination of the dimethylbutyl group and the diazene moiety suggests that this compound may exhibit interesting pharmacological properties. Studies have indicated that azene derivatives can serve as probes for enzyme inhibition and as precursors for drug candidates targeting various diseases. The (E)-configuration of the double bond may also play a crucial role in modulating binding affinity and selectivity when interacting with biological receptors.

The cyano group is particularly noteworthy for its ability to participate in hydrogen bonding interactions and its influence on electronic distribution within the molecule. These characteristics can be exploited to design molecules with specific solubility profiles or metabolic stability. In drug discovery, such properties are critical for optimizing pharmacokinetic parameters. Researchers have leveraged similar structural motifs to develop compounds with enhanced bioavailability and reduced toxicity.

Recent advancements in computational chemistry have enabled more efficient screening of potential drug candidates like 2-(E)-2-(1-cyano-1,3-dimethylbutyl)diazen-1-yl-2,4-dimethylpentanenitrile. Molecular modeling techniques allow scientists to predict how this compound might interact with biological targets at the atomic level. These predictions are invaluable for guiding experimental efforts and reducing the time required to identify promising lead compounds. The integration of experimental data with computational insights has become a cornerstone of modern drug discovery.

The synthesis of 2-(E)-2-(1-cyano-1,3-dimethylbutyl)diazen-1-yl-2,4-dimethylpentanenitrile presents unique challenges due to its complex structure. However, recent innovations in synthetic methodologies have made it more feasible to produce this compound on a scalable basis. Techniques such as transition-metal-catalyzed reactions and asymmetric synthesis have opened new avenues for constructing complex molecules with high precision. These advancements are not only beneficial for academic research but also have practical implications for industrial applications.

The potential applications of this compound extend beyond pharmaceuticals into materials science and agrochemicals. The unique electronic properties of azene derivatives make them attractive candidates for organic electronics and photovoltaic materials. Additionally, their reactivity allows for the development of novel pesticides and herbicides with improved efficacy and environmental safety profiles. As our understanding of these compounds grows, so does their potential to address global challenges in medicine and agriculture.

In conclusion,CAS No. 1547296-70-7 refers to a compound that exemplifies the intersection of synthetic chemistry and medicinal science. Its structural features—such as the (E)-double bond, the cyano group, and the dimethylbutyl moiety—endow it with unique properties that make it a valuable tool for research and development. As scientific methodologies continue to evolve, compounds like 2-(E)-2-(1-cyano-1,3-dimethylbutyl)diazen-1-yl-2,4-dimethylpentanenitrile will undoubtedly play an increasingly significant role in shaping future advancements across multiple disciplines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)